Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D De Vos

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Anticancer Research|May 1, 1991
Cytotoxic activity of di-n-butyltin(IV)(X-A-B-Y) compounds related to salicylic acid against human tumour cellsM Ross, M Gielen, P Lelieveld, et al.
Metal-Based Drugs|May 14, 2008
Synthesis, Characterization and Antitumour Activity of Some Butyltin(IV) Cysteaminates and N,N-DimethylcysteaminatesM Gielen, K Handlir, M Hollein, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 14, 2002
Identification of mebeverine acid as the main circulating metabolite of mebeverine in manArnel Stockis, P J M Guelen, D de Vos
Journal of Chromatography|August 8, 1980
Assay of HA-966 in rat plasma by capillary gas-liquid chromatography with nitrogen-selective detectionH J Broxterman, E L Noach, D de Vos
Scientific Reports|October 6, 2023
Stochastic co-teaching for training neural networks with unknown levels of label noiseBob D de Vos, Gino E Jansen, Ivana Išgum
Pharmaceutisch Weekblad. Scientific Edition|February 19, 1988
The bioavailability of Tamoplex (tamoxifen). Part 3. A steady-state study in breast cancer patientsP H Slee, D De Vos, D Chapman, et al.
A&A Practice|May 27, 2025
Palliative Ultrasound-Guided Cryoneurolysis in a Patient With Breast Cancer: A Case ReportMaya D de Vos, Stefanie T Polderman, Michael K Jew
Pharmaceutisch Weekblad. Scientific Edition|June 25, 1982
Bioavailability of methotrexate tabletsJ H Schornagel, M E Van Engelen, D De Vos
Cancer Chemotherapy and Pharmacology|January 1, 1992
Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancerD de Vos, P H Slee, D Stevenson, et al.
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1987
The bioavailability of Tamoplex (tamoxifen). Part 2. A single dose cross-over study in healthy male volunteersP J Guelen, D Stevenson, R J Briggs, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Anticancer Research|May 1, 1991
Cytotoxic activity of di-n-butyltin(IV)(X-A-B-Y) compounds related to salicylic acid against human tumour cellsM Ross, M Gielen, P Lelieveld, et al.
Metal-Based Drugs|May 14, 2008
Synthesis, Characterization and Antitumour Activity of Some Butyltin(IV) Cysteaminates and N,N-DimethylcysteaminatesM Gielen, K Handlir, M Hollein, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 14, 2002
Identification of mebeverine acid as the main circulating metabolite of mebeverine in manArnel Stockis, P J M Guelen, D de Vos
Journal of Chromatography|August 8, 1980
Assay of HA-966 in rat plasma by capillary gas-liquid chromatography with nitrogen-selective detectionH J Broxterman, E L Noach, D de Vos
Scientific Reports|October 6, 2023
Stochastic co-teaching for training neural networks with unknown levels of label noiseBob D de Vos, Gino E Jansen, Ivana Išgum
Pharmaceutisch Weekblad. Scientific Edition|February 19, 1988
The bioavailability of Tamoplex (tamoxifen). Part 3. A steady-state study in breast cancer patientsP H Slee, D De Vos, D Chapman, et al.
A&A Practice|May 27, 2025
Palliative Ultrasound-Guided Cryoneurolysis in a Patient With Breast Cancer: A Case ReportMaya D de Vos, Stefanie T Polderman, Michael K Jew
Pharmaceutisch Weekblad. Scientific Edition|June 25, 1982
Bioavailability of methotrexate tabletsJ H Schornagel, M E Van Engelen, D De Vos
Cancer Chemotherapy and Pharmacology|January 1, 1992
Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancerD de Vos, P H Slee, D Stevenson, et al.
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1987
The bioavailability of Tamoplex (tamoxifen). Part 2. A single dose cross-over study in healthy male volunteersP J Guelen, D Stevenson, R J Briggs, et al.
Pageof 10